April 17, 2026
HYTN Innovations Inc.
ISIN: CA40443L1040
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
Vancouver, British Columbia, April 17, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and...
Read more >>HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder
VANCOUVER, British Columbia, March 27, 2026. HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic...
Read more >HYTN Appoints Fabian Monaco to Board of Directors
VANCOUVER, British Columbia - Mar 20, 2026 - HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, is pleased...
Read more >HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III
VANCOUVER, British Columbia, December 18, 2025 - HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical-grade cannabis manufacturer, acknowledges the announcement by the...
Read more >